Cubist: Court ruling won't upend Merck takeout

Shares of Cubist Pharmaceuticals Inc. (NASDAQ:CBST) receded slightly in after-hours trading on Monday after surging $26.24 (35%) to $100.60 on news Merck & Co. Inc. (NYSE:MRK) will acquire the biotech for $9.5 billion, including the assumption of $1.1 billion in debt. The

Read the full 424 word article

How to gain access

Continue reading with a
two-week free trial.